IRIS
DE ROSA, GENNARO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 501
EU - Europa 184
AS - Asia 153
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
Totale 852
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 479
SG - Singapore 82
CN - Cina 62
IE - Irlanda 32
IT - Italia 32
FI - Finlandia 30
UA - Ucraina 30
DE - Germania 24
CA - Canada 22
NL - Olanda 20
CI - Costa d'Avorio 10
GB - Regno Unito 5
MK - Macedonia 4
PS - Palestinian Territory 4
SE - Svezia 4
VN - Vietnam 4
EU - Europa 2
PE - Perù 2
SI - Slovenia 2
CZ - Repubblica Ceca 1
MY - Malesia 1
Totale 852
Salva come PNG Salva come JPEG
Città #
Chandler 72
Singapore 71
Jacksonville 38
Millbury 30
Princeton 29
Nanjing 23
Boston 21
Amsterdam 20
Ottawa 19
Ashburn 16
Santa Clara 14
Des Moines 12
Wilmington 12
Beijing 10
Munich 7
Nanchang 7
Dong Ket 4
Naples 4
Napoli 4
Shenyang 4
Skopje 4
Woodbridge 4
Changsha 3
Hamilton 3
Hebei 3
Mountain View 3
Redwood City 3
Tampa 3
Brindisi 2
Cinisello Balsamo 2
Guangzhou 2
Jiaxing 2
Kunming 2
Lima 2
Sterling 2
Tianjin 2
Tulkarm 2
Anghiari 1
Ann Arbor 1
Brno 1
Dallas 1
Forest City 1
Genova 1
Gützkow 1
Helsinki 1
Indiana 1
Kuala Lumpur 1
Lanzhou 1
Los Angeles 1
Milan 1
Nanning 1
Novara 1
Ostra 1
Saluzzo 1
Sandston 1
Saronno 1
Vicenza 1
Washington 1
Totale 482
Salva come PNG Salva come JPEG
Nome #
Clinical relevance of intrahepatic hepatitis B virus DNA in HBsAg-negative HBcAb-positive patients undergoing hematopoietic stem cell transplantation for hematological malignancies. 53
Donor lymphocyte infusion for post-transplant relapse of Hodgkin's lymphoma 48
ALEMTUZUMAB FOR APLASTIC ANEMIA AND RELATED IMMUNE-MEDIATED BONE MARROW FAILURES: LONG-TERM FOLLOW UP OF A PILOT STUDY 44
PEGYLATED-FILGRASTIM AFTER AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION: SINGLE CENTRE EXPERIENCE 39
CIRCULATING MEGAKARYOCYTE-DERIVED CELLS DETECTED BY FLOW CYTOMETRY AS MARKER OF AGGRESSIVE NEOPLASM OF MEGAKARYOCYTIC LINEAGE IN ACUTE MEGAKARYOBLASTIC LEUKEMIA AND ALLIED MALIGNANCIES PRESENTING AS PRIMARY MYELOFIBROSIS 38
PEG-FILGRASTIM AFTER AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION : A SINGLE-CENTRE EXPERIENCE 38
Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial 37
ACCELERATED AND PERSISTENT BONE LOSS AFTER AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION 37
Early hematopoietic zinc finger protein (EHZF), the human homologue to mouse Evi3, is highly expressed in primitive human hematopoietic cells 35
CHRONIC GRAFT Vs HOST DISEASE OF THE GENITAL TRACT: DIAGNOSIS, CLINICAL IMPACT AND MANAGEMENT FROM SURVEILLANCE PROGRAM IN A PRELIMINARY COHORT 33
Accelerated bone mass senescence after hematopoietic stem cell transplantation. 32
Gonadal status in reproductive age women after haematopoietic stem cell transplantation for haematological malignancies 31
Avid (67)Ga uptake in multiple myeloma relapsing after bone marrow transplant 30
THIOTEPA AND MELPHALAN AS NEW CONDITIONING REGIMEN FOR AUTOLOGOUS TRANSPLANTATION IN MULTIPLE LYELOMA 30
Avascular necrosis in long-term survivors after allogeneic or autologous stem cell transplantation: a single center experience and a review 29
XM02 PLUS CHEMOTHERAPY IS SAFE AND EFFECTIVE IN STEM CELL MOBILIZATION FOR PATIENTS CANDIDATED TO AUTOLOGOUS STEM CELL TRANSPLANTATION 29
High serum leptin in patients with chronic graft versus host disease after hematopoietic stem cell transplantation. 28
Gonadal status in reproductive age women after haematopoietic stem cell transplantation for haematological malignancies 27
Estrogen-progestin therapy in women after stem cell transplant: our experience and literature review. 26
THIOTEPA-BASED Vs TBI-BASED MYELOABLATIVE CONDITIONING PRIOR TO ALLOGENEIC STEM CELL TRANSPLANTATION (HSCT) FOR ACUTE MYELOID LEUKEMIA (AML) IN FIRST COMPLETE REMISSION (CR1): A RETROSPECTIVE ANALYSIS FROM THE ALWP OF THE EBMT 26
Transient and persistent endocrine disorders in autologous stem cell transplanted patients. 25
THIOTEPA-BASED Vs TBI-BASED MYELOABLATIVE CONDITIONING PRIOR TO ALLOGENEIC STEM CELL TRANSPLANTATION (HSCT) FOR ACUTE MYELOID LEUKEMIA (AML) IN FIRST COMPLETE REMISSION (CR1): A RETROSPECTIVE ANALYSIS FROM THE ALWP OF EBMT 24
Gonadal status in reproductive age after haematopoietic stem cell transplantation for haematological malignancies. 23
Endocrine disorders during the first year after autologous stem-cell transplant 22
THIOTEPA-BASED HIGH-DOSE PREPARATION Vs BEAM FOR AUTOLOGOUS HEMOPOIETIC STEM CELL TRANSPLANTATION (AUTOHSCT) IN LYMPHOMA OTHER THAN PCNSL: A RETROSPECTIVE UPDATE FROM THE EBMT 19
Thyroid dysfunction after autologous hematopoietic stem cell transplant. 18
Estrogen-progestogen induced hematocolpometra following allogenic stem cell transplant. 18
WHAT IS THE BEST CONDITIONING FOR AUTO-TRANSPLANT IN AML PATIENTS? 17
Tc99m-sestaMIBI uptake in nonsecretory multiple myeloma. 12
Totale 868
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.472
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.472
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202042 0 0 0 0 0 0 0 0 0 1 15 26
2020/202163 0 10 6 6 7 10 7 0 7 0 6 4
2021/2022181 2 0 0 0 0 8 0 5 34 7 54 71
2022/2023182 29 13 8 1 24 17 1 22 37 21 6 3
2023/2024122 4 27 12 4 12 12 2 12 1 1 24 11
2024/2025125 41 43 0 9 32 0 0 0 0 0 0 0
Totale 868